BR100 Increased By (0.39%)
BR30 Increased By (0.47%)
KSE100 Increased By (0.99%)
KSE30 Increased By (1.19%)
AGHA 6.50 Increased By ▲ 0.18 (2.85%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.45 No Change ▼ 0.00 (0%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.81 Increased By ▲ 0.22 (1.9%)
CSIL 5.95 Increased By ▲ 0.23 (4.02%)
FCCL 61.30 Decreased By ▼ -0.24 (-0.39%)
FFL 14.88 Decreased By ▼ -0.14 (-0.93%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.29 Increased By ▲ 0.03 (0.48%)
KOSM 6.00 Increased By ▲ 0.44 (7.91%)
LOTCHEM 24.85 Increased By ▲ 0.17 (0.69%)
MLCF 104.13 Increased By ▲ 0.05 (0.05%)
NBP 174.66 Decreased By ▼ -0.62 (-0.35%)
NCPL 52.83 Increased By ▲ 0.06 (0.11%)
NPL 54.48 Increased By ▲ 0.36 (0.67%)
OGDC 315.35 Increased By ▲ 1.96 (0.63%)
PACE 9.41 Increased By ▲ 0.21 (2.28%)
PAEL 35.62 Decreased By ▼ -0.18 (-0.5%)
PIBTL 13.71 Increased By ▲ 0.24 (1.78%)
PPL 223.38 Increased By ▲ 1.57 (0.71%)
PRL 80.79 Increased By ▲ 1.71 (2.16%)
PTC 47.15 Increased By ▲ 0.30 (0.64%)
SSGC 24.15 Increased By ▲ 0.28 (1.17%)
TBL 9.25 Decreased By ▼ -0.06 (-0.64%)
TELE 7.53 Increased By ▲ 0.14 (1.89%)
TPL 24.89 Decreased By ▼ -0.22 (-0.88%)
TPLP 12.88 Increased By ▲ 0.37 (2.96%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 53.75 Increased By ▲ 0.31 (0.58%)
By

LONDON: British ministers are making plans to distribute millions of free coronavirus antibody tests after a version backed by the UK government passed its first major trials, the Daily Telegraph newspaper reported on Friday.

The fingerprick tests, which can tell within 20 minutes if a person has ever been exposed to the coronavirus, were found to be 98.6% accurate in secret human trials held in June, the newspaper reported.

It added the test was developed by the UK Rapid Test Consortium (UK-RTC), a partnership between Oxford University and leading UK diagnostics firms.

Britain's only antibody tests approved thus far have involved blood samples being sent to laboratories for analysis, which can take days, The Telegraph said.

Comments

Comments are closed for this article.